1. Home
  2. BMRA vs LGVN Comparison

BMRA vs LGVN Comparison

Compare BMRA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • LGVN
  • Stock Information
  • Founded
  • BMRA 1971
  • LGVN 2014
  • Country
  • BMRA United States
  • LGVN United States
  • Employees
  • BMRA N/A
  • LGVN N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • BMRA Health Care
  • LGVN Health Care
  • Exchange
  • BMRA Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • BMRA 9.8M
  • LGVN 7.8M
  • IPO Year
  • BMRA N/A
  • LGVN 2021
  • Fundamental
  • Price
  • BMRA $0.37
  • LGVN $4.35
  • Analyst Decision
  • BMRA
  • LGVN Strong Buy
  • Analyst Count
  • BMRA 0
  • LGVN 1
  • Target Price
  • BMRA N/A
  • LGVN $12.00
  • AVG Volume (30 Days)
  • BMRA 85.8K
  • LGVN 27.4M
  • Earning Date
  • BMRA 08-23-2024
  • LGVN 08-09-2024
  • Dividend Yield
  • BMRA N/A
  • LGVN N/A
  • EPS Growth
  • BMRA N/A
  • LGVN N/A
  • EPS
  • BMRA N/A
  • LGVN N/A
  • Revenue
  • BMRA $5,405,208.00
  • LGVN $978,000.00
  • Revenue This Year
  • BMRA N/A
  • LGVN $137.24
  • Revenue Next Year
  • BMRA N/A
  • LGVN $50.77
  • P/E Ratio
  • BMRA N/A
  • LGVN N/A
  • Revenue Growth
  • BMRA N/A
  • LGVN N/A
  • 52 Week Low
  • BMRA $0.27
  • LGVN $0.77
  • 52 Week High
  • BMRA $2.13
  • LGVN $37.50
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 23.80
  • LGVN 68.96
  • Support Level
  • BMRA $0.28
  • LGVN $3.80
  • Resistance Level
  • BMRA $0.51
  • LGVN $6.40
  • Average True Range (ATR)
  • BMRA 0.05
  • LGVN 0.50
  • MACD
  • BMRA -0.00
  • LGVN 0.25
  • Stochastic Oscillator
  • BMRA 37.78
  • LGVN 49.76

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: